Computer-aided drug design (CADD) and virtual screening techniques to identify potential inhibitors targeting key SARS-CoV-2 proteins. Lead compounds were further evaluated through in silico pharmacokinetics (ADME) and toxicity profiling to assess their drug-likeness and safety. The findings highlight promising candidate molecules with favorable binding affinity and pharmacokinetic properties, supporting their potential for further experimental validation.
Comprar ahora
- Citar trabajo
- Sayra Lia (Autor), 2021, Computer Aided Drug Design and Pharmacokinetics Profiling Against COVID-19 Using Virtual Screening Method, Múnich, GRIN Verlag, https://www.grin.com/document/1711569
Leer eBook
